Literature DB >> 21642334

Opt-out HIV testing: an ethical analysis of women's reproductive rights.

Loren Fields1, Clair Kaplan.   

Abstract

As the HIV epidemic continues to grow worldwide, women are increasingly and disproportionally affected. With the introduction of anti-retroviral medications that have been found to effectively prevent perinatal transmission of HIV, the approach to HIV testing in pregnant women has grown increasingly more controversial. In recent years, the model of voluntary counseling and testing (VCT) has come into question with opt-out testing now advocated for by the Centers for Disease Control and occurring widely in pregnancy. The benefits of opt-out testing are numerous and may justify its use in replacing the VCT that many have come to see as insufficient. An ethical analysis of opt-out testing suggests it may be at odds with true informed consent and involve a degree of coercion that would not be allowed outside the prenatal setting. If opt-out testing is going to remain the standard of care then the ethical issues it raises must be made transparent. Strategies need to be designed for ensuring that HIV counseling and testing in pregnancy is done in accordance with ethical and reproductive rights principles.

Entities:  

Mesh:

Year:  2011        PMID: 21642334     DOI: 10.1177/0969733011403555

Source DB:  PubMed          Journal:  Nurs Ethics        ISSN: 0969-7330            Impact factor:   2.874


  2 in total

Review 1.  The impact of criminalization of HIV non-disclosure on the healthcare engagement of women living with HIV in Canada: a comprehensive review of the evidence.

Authors:  Sophie E Patterson; M-J Milloy; Gina Ogilvie; Saara Greene; Valerie Nicholson; Micheal Vonn; Robert Hogg; Angela Kaida
Journal:  J Int AIDS Soc       Date:  2015-12-22       Impact factor: 5.396

Review 2.  Ethical issues surrounding the provider initiated opt--Out prenatal HIV screening practice in Sub-Saharan Africa: a literature review.

Authors:  Luchuo Engelbert Bain; Kris Dierickx; Kristien Hens
Journal:  BMC Med Ethics       Date:  2015-10-24       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.